University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
NCT Number: NCT04900675
Increased stress levels are a significant problem for many students and represent a risk factor for impaired mental and physical health as well as academic performance. Stress levels are particularly high during the preparation phase for major exams.
There is good evidence that light therapy is an effective treatment option to improve mood in affective disorders.
The present study aims at investigating the psychophysiological effects of a 3-week morning bright light exposure in reducing stress and stress-related problems in students preparing for major exams.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Innsbruck, Tyrol, 6020, Austria
Increased students' stress represents a significant risk factor for impaired mental and physical health as well as academic performance. The World Mental Health Survey (WHO) reports a 12-month prevalence of mental illness of 20.3% among students, with anxiety disorders (14.7%), affective disorders (9.9%), and substance abuse (6.7%) being particularly prominent. Moreover, six out of 10 students suffer from impaired sleep quality.
Offering an effective treatment for stress-related symptoms in students is a challenge. In situations of intense stress, conventional methods such as relaxation and mindfulness-based programs often fail because of poor prior practice. Only a few students apply cognitive behavioral interventions. Although medication might decrease stress symptoms within days, the side effects of drugs cannot be ignored. Therefore, there is a need for effective and efficient treatment of acute stress symptoms in students.
Bright light therapy is an effective treatment for several mental disorders, e.g. affective disorders and sleep disorders. There is some evidence, that exposure to bright light may even reduce stress in patients with burnout symptoms. Thus, exposure to bright light may be a promising new option to reduce academic stress and improve mood and sleep parameters.
In the present study, a large-area desk lamp, which emits diffuse light and is controllable in its luminance and correlated color temperature is used. Study participants are randomly assigned to one of three study arms: (i) exposure to polychromatic light of 5,000 lux and 5,300 Kelvin, (ii) exposure to polychromatic light of 50 lux and 2,200 Kelvin, or (iii) no light intervention. Data collection takes place in winter periods.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exposure with 5,000 lux at eye level for one hour and a Correlated Color Temperature of 5,300 Kelvin every morning for three weeks.
Exposure with 50 lux at eye level for one hour and a Correlated Color Temperature of 2,200 Kelvin every morning for three weeks.
Time frame: Change from baseline PSS-10 sum score at the end of week 3
Perceived Stress Scale (PSS-10); scale: PSS-10 sum score; range:0 - 40; higher scores mean a higher subjective stress level
Time frame: Change from baseline PSQ-20 sum score at the end of week 3
Perceived Stress Questionnaire (PSQ-20); scale: PSQ-20 sum score; range: 20 - 80; higher scores mean a higher subjective stress level
Time frame: Change of daily PSQ-20 sum score at each weekday during the light intervention period up to 3 weeks
Perceived Stress Questionnaire (PSQ-20); scale: PSQ-20 sum score; range: 20 - 80; higher scores mean a higher subjective stress level
Time frame: Change from baseline STAI-trait sum score at the end of week 3
State-Trait Anxiety Inventory (STAI - form Y) - 20 trait items; scale: STAI-trait sum score; range: 20 - 80; higher scores mean a higher subjective anxiety level
Time frame: Change from baseline CES-D sum score at the end of week 3
Center for Epidemiologic Studies Depression Scale (CES--D); scale: CES-D sum score; range: 0 - 60; higher scores mean a higher subjective depression level
Time frame: Change from baseline global PSQI score at the end of week 3
Pittsburgh Sleep Quality Index (PSQI); scale: global PSQI score; range: 0 - 21; higher scores mean a lower subjective sleep quality
Time frame: Change of TST at each night during the light intervention period up to 3 weeks
Wrist actimetry to measure daily total sleep time (TST); scale: sleep duration; range: >0 (minutes); higher TST means longer sleep period
Time frame: change of SOL at each night during the light intervention period up to 3 weeks
Wrist actimetry to measure daily sleep onset latency (SOL); scale: duration to fall asleep; range: >0 (minutes); higher SOL means longer period to fall asleep
Time frame: change of WASO at each night during the light intervention period up to 3 weeks
Wrist actimetry to measure daily wake after sleep onset (WASO); scale: duration of being awake during sleep period; range: greater than or equal to 0 (minutes); higher WASO means longer wake periods after sleep onset
Time frame: change of SE at each night during the light intervention period up to 3 weeks
Wrist actimetry to measure daily sleep efficiency (SE); scale: percentage; range: 0 - 100; higher SE means a higher undisturbed sleep
Time frame: change of IV at each of the three light intervention weeks up to 3 weeks
Circadian rest-activity cycle parameter interdaily stability (IS) derived from weekly wrist actimetry data; scale: real number; range: 0 -1; higher IS means a higher stability in daily rest-activity cycles
Time frame: change of IS at each of the three light intervention weeks up to 3 weeks
Circadian rest-activity cycle parameter intradaily variability (IV) derived from averaged wrist actimetry data over a period of 1 week; scale: real number; range: 0 - 2; higher IV means a higher variability in 24-h rest-activity cycle
Time frame: Change from baseline hair cortisol level at the end of week 3
cortisol level measured from hair sample; scale: real number (pg/mg); range: >0; higher hair cortisol level means higher physiological stress
Time frame: day 5
astenopic complaints measured with 12 items; scale: sum score; range: 10 - 60; higher sum score means more astenopic complaints
Time frame: day 15
astenopic complaints scale measured with 12 items: sum score; range: 10 - 60; higher sum score means more astenopic complaints
Time frame: Change from baseline RS-11 sum score at the end of week 3
Resilience Scale (RS-11); scale: RS-11 sum score; range: 11 - 77; higher RS-11 sum score means more perceived resilience
Time frame: Change from baseline multidimensional CISS scale at the end of week 3
Coping Inventory for Stressful Situations (CISS) - 24 items; three-dimensional CISS scale: (a) task-oriented coping; (b) emotion-oriented coping, and (c) avoidance-oriented coping; range for each dimension: 8 - 40; higher score in each dimension means higher preference for particular stress coping style
Time frame: Change from baseline multidimensional LIST-K scale at the end of week 3
Learning Strategies of University Students (LIST-K) - 36 items; multidimensional LIST-K scale: 13 subscales; range for each dimension: 3 - 15; higher score in each dimension means higher preference for particular learning strategy
Time frame: Change from baseline BSI-18 overall score at the end of week 3
Brief Symptom Inventory (BSI-18); scale: BSI-18 sum score; range: 18 - 90; higher BSI-18 sum score means higher psychological distress
Time frame: Change from baseline SSS-8 sum score at the end of week 3
The somatic symptom scale (SSS-8); scale: SSS-8 sum score; range: 0 - 32; higher SSS-8 sum score means higher somatic complaints
Time frame: day 5
2 items: (a) recommendation of light intervention to a friend and (b) follow-up usage of light intervention for own purposes; scale: binary score ('yes', 'no'); range: 0 - 1; higher binary scores indicate recommendation and follow-up usage of the light intervention
Time frame: day 15
2 items: (a) recommendation of light intervention to a friend and (b) follow-up usage of light intervention for own purposes; scale: binary score ('yes', 'no'); range: 0 - 1; higher binary scores indicate recommendation and follow-up usage of the light intervention
Time frame: changes from before the light intervention of the two-dimensional PANAS scale at the end of light intervention at each weekday during the light intervention period up to 3 weeks
Positive and Negative Affect Schedule (PANAS); two-dimensional PANAS scale: sum score for positive and negative mood state; range for each dimension: 10 - 50; higher PANAS scores mean higher positive and negative mood state, respectively
Time frame: changes in SRM scores in week 1, week 2, and week 3
The Social Rhythm Metric (SRM) measures the regularity in the occurance of 17 daily events; scale: SRM score; range: 0 - 7; higher SRM scores mean more regular occurance of daily events
Time frame: changes from before the light intervention STAI-state sum score at the end of light intervention in week 1, week 2, and week 3
State-Trait Anxiety Inventory (STAI - form Y) - 20 state items; scale: STAI-state sum score; range: 20 - 80; higher scores mean a higher subjective current anxiety level
Time frame: changes from before the light intervention NLT number of correct answers at the end of light intervention in week 1, week 2, and week 3
The Number Letter Task (NLT) measures task switching performance; scale: number of correct answers; range: integer greater than or equal to 0; higher NLT scores means a better task switching performance
Time frame: changes of multidimensional PAF scale at week 1, week 2, and week 3
German Test Anxiety Inventory (PAF); four-dimensional PAF scale: (a) excitement, (b) concern, (c) interference, and (d) lack of confidence; range for each dimension: 5 - 20; higher scale means higher test anxiety in the corresponding dimension
Universitaet Innsbruck
Other
Effects of Bright Morning Light Exposure on Students' Stress, Mood, Anxiety, Sleep and, Circadian Rest-activity Cycle
Acronym: BLISS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02075424
Behavior, Behavioral Symptoms
Metz, France
View Trial DetailsNCT05506644
Anxiety, Anxiety Disorders
San Diego, California, United States
View Trial DetailsNCT06051500
Behavior, Behavioral Symptoms
Madison, Wisconsin, United States
View Trial DetailsNCT05832632
Behavior, Behavioral Symptoms
Odense, Denmark
View Trial Details